Titre : Phénylurées

Phénylurées : Questions médicales fréquentes

Termes MeSH sélectionnés :

Quantitative Structure-Activity Relationship
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Phénylurées : Questions médicales les plus fréquentes", "headline": "Phénylurées : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Phénylurées : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-12", "dateModified": "2025-03-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Phénylurées" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dérivés du benzène", "url": "https://questionsmedicales.fr/mesh/D001555", "about": { "@type": "MedicalCondition", "name": "Dérivés du benzène", "code": { "@type": "MedicalCode", "code": "D001555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dérivés de la diphényl-urée", "alternateName": "Carbanilides", "url": "https://questionsmedicales.fr/mesh/D002224", "about": { "@type": "MedicalCondition", "name": "Dérivés de la diphényl-urée", "code": { "@type": "MedicalCode", "code": "D002224", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.202" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Imidocarbe", "alternateName": "Imidocarb", "url": "https://questionsmedicales.fr/mesh/D007095", "about": { "@type": "MedicalCondition", "name": "Imidocarbe", "code": { "@type": "MedicalCode", "code": "D007095", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.202.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Céliprolol", "alternateName": "Celiprolol", "url": "https://questionsmedicales.fr/mesh/D017272", "about": { "@type": "MedicalCondition", "name": "Céliprolol", "code": { "@type": "MedicalCode", "code": "D017272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.241" } } }, { "@type": "MedicalWebPage", "name": "Diuron", "alternateName": "Diuron", "url": "https://questionsmedicales.fr/mesh/D004237", "about": { "@type": "MedicalCondition", "name": "Diuron", "code": { "@type": "MedicalCode", "code": "D004237", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.397" } } }, { "@type": "MedicalWebPage", "name": "Linuron", "alternateName": "Linuron", "url": "https://questionsmedicales.fr/mesh/D008044", "about": { "@type": "MedicalCondition", "name": "Linuron", "code": { "@type": "MedicalCode", "code": "D008044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.515" } } } ], "about": { "@type": "MedicalCondition", "name": "Phénylurées", "alternateName": "Phenylurea Compounds", "code": { "@type": "MedicalCode", "code": "D010671", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Lin Hao", "url": "https://questionsmedicales.fr/author/Lin%20Hao", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China." } }, { "@type": "Person", "name": "Chun Wang", "url": "https://questionsmedicales.fr/author/Chun%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China. chunwang69@126.com." } }, { "@type": "Person", "name": "Qiuhua Wu", "url": "https://questionsmedicales.fr/author/Qiuhua%20Wu", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China. qiuhuawu@126.com." } }, { "@type": "Person", "name": "Zhi Wang", "url": "https://questionsmedicales.fr/author/Zhi%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China." } }, { "@type": "Person", "name": "Weihua Liu", "url": "https://questionsmedicales.fr/author/Weihua%20Liu", "affiliation": { "@type": "Organization", "name": "College of Science, Hebei Agricultural University, Baoding 071001, Hebei, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Leveraging Cell Painting Images to Expand the Applicability Domain and Actively Improve Deep Learning Quantitative Structure-Activity Relationship Models.", "datePublished": "2023-06-16", "url": "https://questionsmedicales.fr/article/37327474", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.chemrestox.2c00404" } }, { "@type": "ScholarlyArticle", "name": "Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36807581", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jafc.2c07264" } }, { "@type": "ScholarlyArticle", "name": "Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na", "datePublished": "2023-06-24", "url": "https://questionsmedicales.fr/article/37354314", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s43440-023-00508-x" } }, { "@type": "ScholarlyArticle", "name": "Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37021557", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jsfa.12608" } }, { "@type": "ScholarlyArticle", "name": "Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.", "datePublished": "2023-04-18", "url": "https://questionsmedicales.fr/article/37070956", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.molpharmaceut.2c01117" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Phénylurées", "item": "https://questionsmedicales.fr/mesh/D010671" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Phénylurées - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Phénylurées", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-04", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Phénylurées", "description": "Comment diagnostiquer une intoxication aux phénylurées ?\nQuels tests sont utilisés pour détecter les phénylurées ?\nQuels symptômes indiquent une exposition aux phénylurées ?\nLes phénylurées sont-elles détectables par imagerie ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Phénylurées", "description": "Quels sont les symptômes courants des phénylurées ?\nLes phénylurées provoquent-elles des réactions allergiques ?\nPeut-on avoir des symptômes neurologiques ?\nLes symptômes varient-ils selon la dose ?\nY a-t-il des symptômes à long terme ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Phénylurées", "description": "Comment prévenir l'exposition aux phénylurées ?\nLes travailleurs doivent-ils être formés ?\nDes contrôles réguliers sont-ils nécessaires ?\nLes enfants sont-ils plus à risque ?\nQuelles mesures de sécurité doivent être appliquées ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Phénylurées", "description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour les phénylurées ?\nComment gérer les symptômes neurologiques ?\nLe traitement nécessite-t-il une hospitalisation ?\nY a-t-il des traitements préventifs ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Phénylurées", "description": "Quelles complications peuvent survenir ?\nLes phénylurées peuvent-elles causer des cancers ?\nY a-t-il des effets sur la reproduction ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Phénylurées", "description": "Quels sont les principaux facteurs de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes personnes âgées sont-elles plus à risque ?\nLes femmes enceintes doivent-elles être prudentes ?\nLes habitudes de vie influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux phénylurées ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests sanguins et l'évaluation des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les phénylurées ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux phénylurées ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles neurologiques, des éruptions cutanées et des nausées." } }, { "@type": "Question", "name": "Les phénylurées sont-elles détectables par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'imagerie ne détecte pas les phénylurées, des tests biochimiques sont nécessaires." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les expositions potentielles aux phénylurées." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des phénylurées ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des vertiges et des troubles digestifs." } }, { "@type": "Question", "name": "Les phénylurées provoquent-elles des réactions allergiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer des éruptions cutanées et des démangeaisons chez certains individus." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme des convulsions ou des troubles de la coordination peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Y a-t-il des symptômes à long terme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des effets neurologiques ou rénaux peuvent persister après une exposition prolongée." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux phénylurées ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits chimiques contenant des phénylurées et portez des équipements de protection." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle." } }, { "@type": "Question", "name": "Des contrôles réguliers sont-ils nécessaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers de l'environnement de travail peuvent réduire les risques." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets des phénylurées." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être appliquées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des gants, des masques et des lunettes de protection lors de la manipulation." } }, { "@type": "Question", "name": "Quel est le traitement principal pour l'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste en l'élimination de l'exposition et le soutien symptomatique." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les phénylurées ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment gérer les symptômes neurologiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anticonvulsivants peuvent être prescrits pour contrôler les convulsions." } }, { "@type": "Question", "name": "Le traitement nécessite-t-il une hospitalisation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une hospitalisation peut être nécessaire en cas de symptômes graves ou persistants." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition aux phénylurées est la meilleure prévention contre l'intoxication." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, rénales ou hépatiques peuvent se développer après exposition." } }, { "@type": "Question", "name": "Les phénylurées peuvent-elles causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien potentiel avec des cancers, mais des recherches sont nécessaires." } }, { "@type": "Question", "name": "Y a-t-il des effets sur la reproduction ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des effets néfastes sur la reproduction ont été observés dans certains modèles animaux." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des examens médicaux réguliers et des tests de fonction organique sont recommandés." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition professionnelle, l'utilisation de produits chimiques et la génétique sont des facteurs clés." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies peuvent augmenter le risque d'effets néfastes." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus vulnérables aux effets des phénylurées." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles être prudentes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes enceintes doivent éviter l'exposition en raison des risques pour le fœtus." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de vie saines peuvent réduire le risque d'effets néfastes." } } ] } ] }

Sources (10000 au total)

Leveraging Cell Painting Images to Expand the Applicability Domain and Actively Improve Deep Learning Quantitative Structure-Activity Relationship Models.

The search for chemical hit material is a lengthy and increasingly expensive drug discovery process. To improve it, ligand-based quantitative structure-activity relationship models have been broadly a...

Design, Synthesis, Antibacterial Evaluation, Three-Dimensional Quantitative Structure-Activity Relationship, and Mechanism of Novel Quinazolinone Derivatives.

Plant bacterial illnesses are common and cause dramatic damage to agricultural goods all over the world, yet there are few efficient bactericides to alleviate them at present. To discover novel antiba...

Automated machine learning approach for developing a quantitative structure-activity relationship model for cardiac steroid inhibition of Na

Quantitative structure-activity relationship (QSAR) modeling is a method of characterizing the relationship between chemical structures and biological activity. Automated machine learning enables comp... The chemical structures and inhibitory activities of 215 CS derivatives were obtained from the scientific literature. Predictive QSAR models were constructed using molecular descriptors, fingerprints,... The best predictive QSAR models were selected based on the LogLoss value. Using these models, the Matthews correlation coefficient, F1 score, and area under the curve of the test dataset were 0.6729, ... The automated machine learning-based QSAR method developed here should be applicable for the time-efficient construction of predictive models using only a small number of compounds....

Multivariate image analysis applied to quantitative structure-activity relationships and docking studies of recent hydroxyphenylpyruvate deoxygenase inhibitors.

Mesotrione is a triketone widely used as an inhibitor of the hydroxyphenylpyruvate deoxygenase (HPPD) enzyme. However, new agrochemicals should be developed continuously to tackle the problem of herbi... The MIA-QSAR models based on van der Waals radii (r... Multivariate image analysis descriptors corroborated by docking studies were capable of modeling the herbicidal activities of 68 triketones reliably. Due to the substituent effects at the triketone fr...

Artificial Intelligence-Based Quantitative Structure-Property Relationship Model for Predicting Human Intestinal Absorption of Compounds with Serotonergic Activity.

Oral medicines represent the largest pharmaceutical market area. To achieve a therapeutic effect, a drug must penetrate the intestinal walls, the main absorption site for orally delivered active pharm...

Development of a quantitative structure-activity relationship model for predicting quantum yield of hydroxyl radical generation from organic compounds.

Organic compounds are capable of generating hydroxyl radicals (˙OH) through their excited triplet states in natural water. It is of significance to reveal the underlying mechanism of the generation an...

In vitro and Quantitative and Structure Activity Relationship (QSAR) evaluation of the antifungal activity of terpenoid constituents of essential oils against Alternaria alternata and Fusarium oxysporum

Fungal genera Alternaria and Fusarium include human and plant pathogenic species. Several antifungals have been used for their control, but excessive use has contributed to resistance development in p... To evaluate in vitro and in silico the antifungal activities of terpenoids against Alternaria alternata and Fusarium oxysporum.... The minimum inhibitory concentration and minimum fungicidal concentration values of 27 constituents of essential oils used against Alternaria alternata and Fusarium oxysporum were evaluated in vitro. ... The evaluated compounds proved to be effective antifungals. Thymol was the most active with a minimum inhibitory concentration of 91.6 ± 28.8 μg/ml for A. alternata and F. oxysporum. Quantitative stru... Terpenoids exhibit relevant antifungal activities that should be incorporated into the study of medicinal chemistry. Inclusion of in silico assays in the in vitro evaluation is a valuable tool in the ...

Three-dimensional quantitative structural-activity relationship and molecular dynamics study of multivariate substituted 4-oxyquinazoline HDAC6 inhibitors.

3D-QSAR models were established by collecting 46 multivariate-substituted 4-oxyquinazoline HDAC6 inhibitors. The relationship of molecular structure and inhibitory activity was studied by comparative ...

Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure.

The leading cause of atherosclerotic cardiovascular disease (ASCVD) is elevated low-density lipoprotein cholesterol (LDL-C). Proprotein convertase subtilisin/kexin type 9 (PCSK9) attaches to the domai...